The Urine Biomarker PUR-4 Is Positively Associated with the Amount of Gleason 4 in Human Prostate Cancers
The Prostate Urine Risk (PUR) biomarker is a four-group classifier for predicting outcome in patients prior to biopsy and for men on active surveillance. The four categories correspond to the probabilities of the presence of normal tissue (PUR-1), D’Amico low-risk (PUR-2), intermediate-risk (PUR-3),...
Guardado en:
Autores principales: | Richard Y. Ball, Ryan Cardenas, Mark S. Winterbone, Marcelino Y. Hanna, Chris Parker, Rachel Hurst, Daniel S. Brewer, Lauren D’Sa, Rob Mills, Colin S. Cooper, Jeremy Clark |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/da05f8c2ac47466c831676bc9de0f325 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sulfated Hyaluronan coating of polyurethanebased implant materials
por: Kemkemer Ralf, et al.
Publicado: (2020) -
Predicting Gleason score using the initial serum total prostate-specific antigen in Black men with symptomatic prostate adenocarcinoma in Nigeria
por: Nnabugwu II, et al.
Publicado: (2016) -
Evaluation of CD10 Expression and Its Relationship with Gleason Score in Prostatic Adenocarcinoma
por: A Ghasemi, et al.
Publicado: (2021) -
High mortality risk of prostate cancer patients in Asia and West Africa: A systematic review
por: Jude O Okoye
Publicado: (2020) -
Significant Inter- and Intralaboratory Variation in Gleason Grading of Prostate Cancer: A Nationwide Study of 35,258 Patients in The Netherlands
por: Rachel N. Flach, et al.
Publicado: (2021)